Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04402086 · ClinicalTrials.gov registry record
Rheumatology Patient Registry and Biorepository
A clinical trial of Systemic Lupus Erythematosus and Psoriatic Arthritis, sponsored by Yale University.
- Recruiting
- Registry status
- 5,000
- Enrollment target
- 1
- Study location
NCT04402086 is a study of Systemic Lupus Erythematosus and Psoriatic Arthritis that is actively recruiting participants, run by Yale University. The registered enrollment target is 5,000 participants, above the 330-participant average among 99 other Systemic Lupus Erythematosus trials with a reported enrollment target (1415% higher). The trial reports 1 study location across 1 state.
The verdict
NCT04402086, a study of Systemic Lupus Erythematosus and Psoriatic Arthritis, is actively recruiting participants, sponsored by Yale University.
- RECRUITING
- Registry status
- 5,000 participants
- Enrollment target
- 1
- Study location
Study Summary
To facilitate clinical, basic science, and translational research projects involving the study of rheumatic diseases.
Conditions Studied
Study Locations (1)
Connecticut
- Yale New Haven Hospital - New Haven
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5,000 participants |
| Start Date | 2020-08-04 |
| Est. Completion | 2030-06-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04402086
The ClinicalTrials.gov registry entry for NCT04402086 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 5,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 330-participant average among 99 other Systemic Lupus Erythematosus trials with a reported enrollment target (1415% higher). The listed sponsor is Yale University, which has 1,492 total studies on file at ClinicalTrials.gov.
The record links to 10 conditions, with Systemic Lupus Erythematosus appearing as the primary indexed condition, and to 0 interventions.
NCT04402086 reports 1 study location spanning 1 distinct geographic area - top geographies include Connecticut.
Frequently Asked Questions
What is clinical trial NCT04402086 about?
NCT04402086 is a clinical study titled "Rheumatology Patient Registry and Biorepository". To facilitate clinical, basic science, and translational research projects involving the study of rheumatic diseases.
What is the current status of trial NCT04402086?
This trial is currently recruiting. The enrollment target is 5,000 participants. The study started on 2020-08-04. Estimated completion is 2030-06-01.
What conditions does trial NCT04402086 study?
This clinical trial studies the following conditions: Systemic Lupus Erythematosus, Psoriatic Arthritis, Dermatomyositis, Ankylosing Spondylitis, Rheumatic Diseases.
Who is sponsoring clinical trial NCT04402086?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04402086 being conducted?
This trial has 1 study location across Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Systemic Lupus Erythematosus
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Program to Assess Adverse Events and Change in Disease Activity of Oral Upadacitinib in Adult Participants With Moderate to Severe Systemic Lupus Erythematosus
RECRUITING · Phase 3
-
A Study to Evaluate the Safety, Tolerability, Cellular Kinetics, Pharmacodynamics, and Efficacy of P-CD19CD20-ALLO1 in Participants With Severe, Treatment-refractory Systemic Lupus Erythematosus (SLE)
RECRUITING · Phase 1
-
A Study of NKX019, a CD19 CAR NK Cell Therapy, in Subjects With Systemic Lupus Erythematosus
RECRUITING · Phase 1
-
Creating Health Course Study for People With Rheumatological Conditions
RECRUITING · NA
-
Electroencephalogram Recording in Patients With Systemic Lupus Erythematosus
RECRUITING
-
Prospective Registry Investigating Maternal and Infant Outcomes in Anifrolumab Users
RECRUITING
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.